NCT06760468

Brief Summary

Purpose: To optimize the preparation process of probiotic powder and assess its impact on healthy athletes, providing a scientific basis for functional foods. Procedures: Probiotic Powder Preparation: Using vacuum freeze-drying to improve bacterial survival rates. Human Trials: Recruiting healthy athletes aged 20-30, divided into placebo and probiotic powder groups for an 8-week trial. Testing and Analysis: Conducting running exhaustion tests and blood biochemical analysis to evaluate the effects of probiotic powder. Importance: Understanding the effects of probiotics on athletes helps develop better health products.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 26, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 6, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

January 6, 2025

Status Verified

January 1, 2025

Enrollment Period

3 months

First QC Date

December 26, 2024

Last Update Submit

January 3, 2025

Conditions

Outcome Measures

Primary Outcomes (8)

  • Lactic acid

    Lactic acid:Collecting 2 ml of venous blood for measurement indicators

    8 weeks

  • Creatine kinase

    Creatine kinase: Collecting 2 ml of venous blood for measurement indicators.

    8 weeks

  • Blood urea nitrogen

    Blood urea nitrogen: Collecting 2 ml of venous blood for measurement indicators.

    8 weeks

  • Liver glycogen

    Liver glycogen: Collecting 2 ml of venous blood for measurement indicators.

    8 weeks

  • Muscle glycogen

    Muscle glycogen: Collecting 2 ml of venous blood for measurement indicators.

    8 weeks

  • Total superoxide dismutase

    Total superoxide dismutase: Collecting 2 ml of venous blood for measurement indicators.

    8 weeks

  • Glutathione

    Glutathione: Collecting 2 ml of venous blood for measurement indicators.

    8 weeks

  • Malondialdehyde

    Malondialdehyde

    8 weeks

Secondary Outcomes (1)

  • Maximum Oxygen Uptake

    8 weeks

Study Arms (2)

Experimental group

EXPERIMENTAL

Randomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the experimental group. Participants in the experimental group will undergo an 8-week probiotic powder supplementation intervention. The dosage of the probiotic powder is set at 1x10\^9 CFU/kg·bw·d, which means ingesting 10 billion CFU (Colony-Forming Units) of probiotics per kilogram of body weight per day. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the probiotic powder once a day at the same time to ensure the consistency of the dosage and the standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise capacity tests and blood sample collections will be condu

Other: ControlDietary Supplement: Experimental Group

Control group

NO INTERVENTION

Description: Arm Description: Randomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the control group. Participants in the control group will undergo an 8-week placebo supplementation intervention. The placebo has a similar appearance and taste to the probiotic powder but does not contain active probiotic ingredients. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the placebo once a day at the same time to ensure the consistency and standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise capacity tests and blood sample collections will be conducted again. Comparing exercise perf

Interventions

ControlOTHER

Arm Description: Randomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the control group. Participants in the control group will undergo an 8-week placebo supplementation intervention. The placebo has a similar appearance and taste to the probiotic powder but does not contain active probiotic ingredients. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the placebo once a day at the same time to ensure the consistency and standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise capacity tests and blood sample collections will be conducted again. Comparing exercise performance and biochemical markers before and after t

Also known as: Control group
Experimental group
Experimental GroupDIETARY_SUPPLEMENT

Experimental: Arm Description: Randomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the experimental group. Participants in the experimental group will undergo an 8-week probiotic powder supplementation intervention. The dosage of the probiotic powder is set at 1x10\^9 CFU/kg·bw·d, which means ingesting 10 billion CFU (Colony-Forming Units) of probiotics per kilogram of body weight per day. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the probiotic powder once a day at the same time to ensure the consistency of the dosage and the standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise ca

Experimental group

Eligibility Criteria

Age20 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age Range: Individuals aged 20 to 30 years old.
  • Health Status: Healthy, without chronic illnesses or disabilities.
  • Athletic Background: Well-trained athletes with a history of regular physical activity.
  • Lifestyle: No history of smoking or excessive alcohol consumption.
  • Compliance and Consent: Capable of understanding and adhering to study protocols and willing to provide informed consent.

You may not qualify if:

  • Chronic Illnesses: Individuals with unmanaged chronic diseases
  • Substance Use: Current smokers or individuals with a history of substance abuse.
  • Allergies and Supplements: History of food allergies or long-term use of nutritional supplements and medications.
  • Probiotic and Antibiotic Use: Use of probiotics, fermented products, or antibiotics during the study period.
  • Other Conditions: Pregnant or breastfeeding women, individuals with severe mental health conditions, or those participating in other clinical studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

December 26, 2024

First Posted

January 6, 2025

Study Start

February 1, 2025

Primary Completion

May 1, 2025

Study Completion

June 1, 2025

Last Updated

January 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share